Back to IKT
JPMORGAN CHASE & CO IKT Position History
Inhibikase Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$2K
Q3 2026
Peak value
$487K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $41K |
| Q3 2025 | $39K |
| Q3 2025 | $219 |
| Q4 2025 | $949 |
| Q4 2025 | $50K |
| Q4 2025 | $476 |
| Q1 2026 | $430K |
| Q1 2026 | $89K |
| Q1 2026 | $717 |
| Q2 2026 | $121K |
| Q2 2026 | $487K |
| Q2 2026 | $4K |
| Q3 2026 | $160K |
| Q3 2026 | $486K |
| Q3 2026 | $2K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2K | 928 | — | — |
| Q3 2026 | $486K | 240.7K | — | — |
| Q3 2026 | $160K | 79.4K | — | — |
| Q2 2026 | $4K | 1.9K | — | — |
| Q2 2026 | $487K | 252.1K | — | — |
| Q2 2026 | $121K | 62.6K | — | — |
| Q1 2026 | $717 | 454 | — | — |
| Q1 2026 | $89K | 56.1K | — | — |
| Q1 2026 | $430K | 271.9K | — | — |
| Q4 2025 | $476 | 232 | — | — |
| Q4 2025 | $50K | 24.2K | — | — |
| Q4 2025 | $949 | 463 | — | — |
| Q3 2025 | $219 | 135 | — | — |
| Q3 2025 | $39K | 24.4K | — | — |
| Q3 2025 | $41K | 25.4K | — | — |